Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors

Details for Australian Patent Application No. 2007223342 (hide)

Owner Bristol-Myers Squibb Company

Inventors Lin, James; Vrudhula, Vivekananda M.; Leftheris, Katerina; Liu, Chunjian

Agent A J Park

Pub. Number AU-A-2007223342

PCT Pub. Number WO2007/103839

Priority 60/779,851 07.03.06 US

Filing date 5 March 2007

Wipo publication date 13 September 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 11/00 (2006.01) Acyclic unsaturated hydrocarbons

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103839 Priority application(s): WO2007/103839

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007223360-Method and system of interrupting a transmitting subscriber in a wireless communications system

2007223336-A combined face and iris recognition system